European guidance for the diagnosis and management of osteoporosis in postmenopausal women

被引：1351

作者：

Kanis, J. A. ^{[1
,8
]}

McCloskey, E. V. ^{[1
]}

Johansson, H. ^{[1
]}

Cooper, C. ^{[2
,3
]}

Rizzoli, R. ^{[4
,5
]}

Reginster, J. -Y. ^{[6
,7
]}

机构：

[1] UK Univ Sheffield, Sch Med, WHO Collaborating Ctr, Sheffield, S Yorkshire, England

[2] Univ Southampton, MRC Lifecourse Epidemiol Unit, Oxford, England

[3] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England

[4] Univ Hosp, Geneva, Switzerland

[5] Fac Med Geneva, Geneva, Switzerland

[6] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium

[7] Univ Liege, HEC Sch Management, Liege, Belgium

[8] Univ Sheffield, Sch Med, WHO Collaborating Ctr Metab Bone Dis, Sheffield S10 2RX, S Yorkshire, England

来源：

OSTEOPOROSIS INTERNATIONAL | 2013年 / 24卷 / 01期

基金：

英国医学研究理事会;

关键词：

Bone mineral density; Diagnosis of osteoporosis; Fracture risk assessment; FRAX; Health economics; Treatment of osteoporosis; BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; ESTROGEN PLUS PROGESTIN; X-RAY ABSORPTIOMETRY; INCREASED CARDIOVASCULAR RISKS; PRIOR BISPHOSPHONATE THERAPY; HORMONE REPLACEMENT THERAPY; INTRAVENOUS ZOLEDRONIC ACID; FOR-CLINICAL-DENSITOMETRY; VITAMIN-D SUPPLEMENTATION;

D O I：

10.1007/s00198-012-2074-y

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis. The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2008. This manuscript updates these in a European setting. Systematic literature reviews. The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk, general and pharmacological management of osteoporosis, monitoring of treatment, assessment of fracture risk, case finding strategies, investigation of patients and health economics of treatment. A platform is provided on which specific guidelines can be developed for national use.

引用

页码：23 / 57

页数：35

共 277 条

[1]

Adachi JD, 2012, OSTEOPOROS IN PRESS

[2]

Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].

Anderson, GL ;

Limacher, M ;

Assaf, AR ;

Bassford, T ;

Beresford, SAA ;

Black, H ;

Bonds, D ;

Brunner, R ;

Brzyski, R ;

Caan, B ;

Chlebowski, R ;

Curb, D ;

Gass, M ;

Hays, J ;

Heiss, G ;

Hendrix, S ;

Howard, BV ;

Hsia, J ;

Hubbell, A ;

Jackson, R ;

Johnson, KC ;

Judd, H ;

Kotchen, JM ;

Kuller, L ;

LaCroix, AZ ;

Lane, D ;

Langer, RD ;

Lasser, N ;

Lewis, CE ;

Manson, J ;

Margolis, K ;

Ockene, J ;

O'Sullivan, MJ ;

Phillips, L ;

Prentice, RL ;

Ritenbaugh, C ;

Robbins, J ;

Rossouw, JE ;

Sarto, G ;

Stefanick, ML ;

Van Horn, L ;

Wactawski-Wende, J ;

Wallace, R ;

Wassertheil-Smoller, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712

[3]

[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1

[4]

[Anonymous], 2002, GLUC IND OST GUID PR

[5]

[Anonymous], 2008, CLIN GUID PREV TREAT

[6]

[Anonymous], 2011, DON GAL RIV MEM TREA

[7]

[Anonymous], QUEST ANSW SAF PROT

[8]

[Anonymous], 2001, Human Vitamin and Mineral Requirements - Report of a joint FAO/WHO expert consultation

[9]

[Anonymous], 2001, MACROECONOMICS HLTH

[10]

[Anonymous], 2011, OSTEOLOGIE, V20, P55, DOI DOI 10.1055/S-0037-1619980

← 1 2 3 4 5 6 7 8 9 10 →